Non-IgG isotypes become an alternative to IgG used for the treatment of the tumor. Moreover, Non-IgG isotypes may have greater advantages in tumor treatment compared to IgG isotype. Creative Biolabs, a world-leading service provider in the field of non-IgG antibody development, is very proud of providing high-quality non-IgG antibody development
services.